Concert Pharmaceuticals, Inc. (CNCE) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
65 HAYDEN AVENUE LEXINGTON, MA 02421 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2022 MRQ | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 141,600 | 130,000 | 106,400 | 153,300 | 203,200 | 96,200 | |||
| Cash and cash equivalents | 141,636 | 77,202 | 53,043 | 17,770 | 27,665 | 40,555 | |||
| Short-term investments | 1,463 | 54,735 | 58,770 | 143,069 | 175,500 | 55,630 | |||
| Other undisclosed cash, cash equivalents, and short-term investments | (1,499) | (1,937) | (5,413) | (7,539) | 35 | 15 | |||
| Receivables | 218 | 3,177 | 332 | 571 | 155 | 27 | |||
| Contract with customer, asset, after allowance for credit loss | 16,000 | ✕ | ✕ | ||||||
| Deferred costs | 15 | 143 | |||||||
| Other undisclosed current assets | 8,496 | 9,547 | 9,980 | 10,278 | 2,379 | 1,502 | |||
| Total current assets: | 150,329 | 142,724 | 116,855 | 180,149 | 205,734 | 97,729 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 8,585 | 8,968 | 9,252 | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 5,242 | 6,363 | 7,753 | 8,919 | 2,165 | 2,199 | |||
| Restricted cash and investments | 1,157 | 1,157 | 1,157 | 1,157 | 1,557 | 400 | |||
| Other noncurrent assets | 3 | 51 | 96 | 34 | 67 | ||||
| Other undisclosed noncurrent assets | 2,358 | 2,322 | 2,246 | ||||||
| Total noncurrent assets: | 14,987 | 16,539 | 20,616 | 12,398 | 6,002 | 2,666 | |||
| TOTAL ASSETS: | 165,316 | 159,263 | 137,471 | 192,547 | 211,736 | 100,395 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 7,317 | 4,629 | 4,965 | 5,860 | 4,378 | 3,366 | |||
| Taxes payable | ✕ | 390 | 46 | ||||||
| Employee-related liabilities | ✕ | 3,617 | 3,690 | 3,222 | 3,067 | 2,797 | 2,010 | ||
| Accounts payable | 2,606 | 230 | 881 | 1,277 | 658 | 545 | |||
| Accrued liabilities | 1,094 | 709 | 862 | 1,126 | 877 | 811 | |||
| Deferred revenue | 7,783 | ✕ | ✕ | ✕ | |||||
| Debt | 268 | ||||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | 1,546 | 1,274 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | 1,413 | ✕ | ✕ | ||
| Other undisclosed current liabilities | 8,803 | 5,549 | 4,252 | 1,476 | 521 | 930 | |||
| Total current liabilities: | 16,120 | 10,178 | 17,268 | 8,749 | 6,445 | 5,570 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 13,910 | 15,065 | 15,996 | ||||||
| Liabilities, other than long-term debt | 7,623 | 2,858 | 2,750 | 11,970 | 8,859 | 9,231 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | 8,859 | 9,231 | ||
| Accounts payable and accrued liabilities | 28 | 108 | |||||||
| Deferred revenue | 7,595 | 2,750 | 2,750 | ✕ | ✕ | ✕ | |||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | 9,120 | ✕ | ✕ | ||
| Deferred rent credit | 2,850 | ✕ | ✕ | ||||||
| Operating lease, liability | 13,910 | 15,065 | 15,996 | ✕ | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | 15,438 | 4,088 | |||||||
| Total noncurrent liabilities: | 36,971 | 17,923 | 18,746 | 16,058 | 8,859 | 9,231 | |||
| Total liabilities: | 53,091 | 28,101 | 36,014 | 24,807 | 15,304 | 14,801 | |||
| Equity | |||||||||
| Equity, attributable to parent | 112,225 | 131,162 | 101,457 | 167,740 | 196,432 | 85,594 | |||
| Common stock | 34 | 31 | 24 | 23 | 23 | 22 | |||
| Additional paid in capital | 461,765 | 400,636 | 296,145 | 284,369 | 273,059 | 257,461 | |||
| Accumulated other comprehensive loss | (76) | (58) | (31) | (137) | (407) | (7) | |||
| Accumulated deficit | (349,498) | (269,447) | (194,681) | (116,515) | (76,243) | (171,882) | |||
| Total equity: | 112,225 | 131,162 | 101,457 | 167,740 | 196,432 | 85,594 | |||
| TOTAL LIABILITIES AND EQUITY: | 165,316 | 159,263 | 137,471 | 192,547 | 211,736 | 100,395 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 32,578 | 7,902 | 1,077 | 10,505 | 143,891 | 174 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | 143,891 | 174 | |
| Gross profit: | 32,578 | 7,902 | 1,077 | 10,505 | 143,891 | 174 | ||
| Operating expenses | (110,086) | (80,549) | (80,092) | (66,089) | (51,242) | (51,341) | ||
| Operating income (loss): | (77,508) | (72,647) | (79,015) | (55,584) | 92,649 | (51,167) | ||
| Nonoperating income | 46 | 1,202 | 2,999 | 2,799 | 4,122 | 447 | ||
| Investment income, nonoperating | 46 | 1,202 | 2,987 | 2,787 | 1,336 | 447 | ||
| Other nonoperating income | 12 | 12 | 2,786 | |||||
| Interest and debt expense | (1,432) | |||||||
| Income (loss) from continuing operations before income taxes: | (77,462) | (71,445) | (76,016) | (52,785) | 95,339 | (50,720) | ||
| Income tax expense (benefit) | 85 | (313) | 300 | |||||
| Income (loss) from continuing operations: | (77,462) | (71,360) | (76,016) | (53,098) | 95,639 | (50,720) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (77,462) | (71,360) | (76,016) | (53,098) | 95,639 | (50,720) | |
| Net income (loss): | (77,462) | (71,360) | (76,016) | (53,098) | 95,639 | (50,720) | ||
| Other undisclosed net loss attributable to parent | (2,589) | (3,406) | (2,150) | (2,926) | ||||
| Net income (loss) attributable to parent: | (80,051) | (74,766) | (78,166) | (56,024) | 95,639 | (50,720) | ||
| Undistributed earnings (loss) allocated to participating securities, basic | (444) | ✕ | ||||||
| Net income (loss) available to common stockholders, basic: | (80,051) | (74,766) | (78,166) | (56,024) | 95,195 | (50,720) | ||
| Other undisclosed net income available to common stockholders, diluted | 15 | |||||||
| Net income (loss) available to common stockholders, diluted: | (80,051) | (74,766) | (78,166) | (56,024) | 95,210 | (50,720) | ||
Comprehensive Income ($ in thousands)
| 9/30/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (77,462) | (71,360) | (76,016) | (53,098) | 95,639 | (50,720) | ||
| Other comprehensive income (loss) | 95,239 | (50,709) | ||||||
| Comprehensive income (loss): | (77,462) | (71,360) | (76,016) | (53,098) | 190,878 | (101,429) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (2,607) | (3,433) | (2,044) | (2,656) | ||||
| Comprehensive income (loss), net of tax, attributable to parent: | (80,069) | (74,793) | (78,060) | (55,754) | 190,878 | (101,429) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.